Protagonist Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagonist Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.5M | 108k | 22.93 |
| 2023-09-30 | $2.3M | 140k | 16.68 |
| 2023-06-30 | $4.5M | 163k | 27.62 |
| 2023-03-31 | $2.8M | 122k | 23.00 |
| 2022-12-31 | $2.1M | 195k | 10.91 |
| 2022-09-30 | $1.6M | 191k | 8.43 |
| 2020-06-30 | $505k | 29k | 17.66 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management